Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of May 24
 +1.07 / +1.95%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
May 17 / Zacks.com - Paid Partner Content
What Lies Ahead for Biotech ETFs?
May 13 / Zacks.com - Paid Partner Content


1 month-3.36% 3 years+15.83%
3 months+14.72% 5 years+18.87%
1 year-27.86% Since inception+12.98%
Data through 05/25/2016

Quote Details

Previous close$54.81
Open day’s range55.12 – 56.04
Net asset value (NAV)55.96 (05/24/2016)
Daily volume7,289,919
Average volume (3 months)7,506,038
Data as of 05/24/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+18.87%+15.78%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio0.690.97
Net assets$1.8B$1.3B
Average market cap$3.6B$27.9B
Average P/E--24.4
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ACAD ACADIA Pharmaceuticals Inc2.97%
MDVN Medivation Inc2.75%
NBIX Neurocrine Biosciences Inc2.39%
ICPT Intercept Pharmaceuticals Inc2.39%
ALKS Alkermes Plc2.24%
LGND Ligand Pharmaceuticals Inc2.20%
RARE Ultragenyx Pharmaceutical Inc2.09%
AMGN Amgen2.03%
ALNY Alnylam Pharmaceuticals Inc2.00%
NVAX Novavax Inc1.99%

Partner Offers

Search for Jobs